|
G |
Apoe |
apolipoprotein E |
|
IMP |
|
RGD |
PMID:29166645 |
RGD:150520219 |
NCBI chr 1:88,481,889...88,485,816
|
|
G |
Apoeem1Ejt |
apolipoprotein E; TALEN induced mutant 1, Ejt |
|
IMP |
|
RGD |
PMID:29166645 |
RGD:150520219 |
|
|
G |
Apoeem1Sage |
apolipoprotein E; endonuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:29166645 |
RGD:150520219 |
|
|
|
G |
Cd36 |
CD36 molecule |
|
IAGP |
|
RGD |
PMID:18288886 |
RGD:2307226 |
NCBI chr 4:18,209,088...18,302,142
|
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
|
RGD |
PMID:31253878 |
RGD:401976417 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:31253878 |
RGD:401976417 |
|
|
G |
Lrp5 |
LDL receptor related protein 5 |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
NCBI chr 1:200,814,247...200,917,581
|
|
G |
Lrp5em1Vari |
LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
|
|
G |
Lrp5em2Vari |
LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
|
|
G |
Lrp5em3Vari |
LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
|
|
|
G |
Lrp5 |
LDL receptor related protein 5 |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
NCBI chr 1:200,814,247...200,917,581
|
|
G |
Lrp5em1Vari |
LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
|
|
G |
Lrp5em2Vari |
LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
|
|
G |
Lrp5em3Vari |
LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari |
|
IMP |
|
RGD |
PMID:32833527 |
RGD:40902996 |
|
|
G |
Pde6b |
phosphodiesterase 6B |
|
IMP |
compared to wild-type |
RGD |
PMID:31009522 |
RGD:40924664 |
NCBI chr14:1,323,310...1,366,450
|
|
G |
Pde6bem1Baek |
phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek |
|
IMP |
compared to wild-type |
RGD |
PMID:31009522 |
RGD:40924664 |
|
|
|
G |
Cryba1 |
crystallin, beta A1 |
|
IMP |
|
RGD |
PMID:17931883 |
RGD:2303652 |
NCBI chr10:62,608,373...62,614,726
|
|
G |
Cryba1Nuc1Dbsa |
crystallin, beta A1;Nuc1 mutant, Dbsa |
|
IMP |
|
RGD |
PMID:17931883 |
RGD:2303652 |
|
|
G |
Kdr |
kinase insert domain receptor |
|
IDA |
inhibition significantly reduces retinal neovascularization |
RGD |
PMID:15951738 |
RGD:1581593 |
NCBI chr14:32,572,031...32,615,204
|
|
|
G |
Cryba1 |
crystallin, beta A1 |
|
IAGP |
DNA:insertion:exon |
RGD |
PMID:17931883 |
RGD:2303652 |
NCBI chr10:62,608,373...62,614,726
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
IMP |
|
RGD |
PMID:23859880 |
RGD:13204753 |
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Ahrem2Sage |
aryl hydrocarbon receptor; ZFN induced mutant2, Sage |
|
IMP |
|
RGD |
PMID:23859880 |
RGD:13204753 |
|
|
|
G |
Lepr |
leptin receptor |
|
IAGP |
DNA:mutations:cds: : (rat) |
RGD |
PMID:10901178 |
RGD:401965414 |
NCBI chr 5:121,409,735...121,593,201
|
|
|
G |
Mgp |
matrix Gla protein |
|
IDA |
|
RGD |
PMID:17138823 |
RGD:2293588 |
NCBI chr 4:171,497,472...171,500,888
|
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
induces |
IMP |
|
RGD |
PMID:32324784 |
RGD:127345089 |
NCBI chr17:34,383,397...34,435,523
|
|
G |
Agtr1aem5Mcwi |
angiotensin II receptor, type 1a; zinc finger nuclease induced mutant 5, Medical College of Wisconsin |
induces |
IMP |
|
RGD |
PMID:32324784 |
RGD:127345089 |
|
|
G |
Wars2 |
tryptophanyl tRNA synthetase 2 (mitochondrial) |
|
IMP |
|
RGD |
PMID:27389904 |
RGD:127338472 |
NCBI chr 2:186,459,744...186,543,581
|
|
|
G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
exacerbates induces |
IMP |
compared to wild type |
RGD |
PMID:31402164 PMID:31402164 |
RGD:151347602, RGD:151347602 |
NCBI chr 2:234,667,499...234,800,322
|
|
G |
Ddah1em1Ywxu |
dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu |
induces exacerbates |
IMP |
compared to wild type |
RGD |
PMID:31402164 PMID:31402164 |
RGD:151347602, RGD:151347602 |
|
|
|
G |
Lepr |
leptin receptor |
treatment |
IAGP |
|
RGD |
PMID:33568522 |
RGD:401965412 |
NCBI chr 5:121,409,735...121,593,201
|
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
|
IMP |
|
RGD |
PMID:25593290 |
RGD:38500244 |
NCBI chr 9:68,685,942...68,801,353
|
|
G |
Bmpr2em1Ang |
bone morphogenetic protein receptor type 2; ZFN induced mutant 1, Ang |
|
IMP |
|
RGD |
PMID:25593290 |
RGD:38500244 |
|
|
G |
Pld2 |
phospholipase D2 |
|
IDA |
angiotensin II induced |
RGD |
PMID:16113073 |
RGD:1642674 |
NCBI chr10:55,754,957...55,772,819
|
|
G |
Prkcz |
protein kinase C, zeta |
|
IDA |
angiotensin II induced |
RGD |
PMID:16113073 |
RGD:1642674 |
NCBI chr 5:171,101,774...171,212,694
|
|